Editorials

All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic Leukemia

Leukemia Service, Memorial Sloan Kettering Cancer Center
Leukemia Service, Memorial Sloan Kettering Cancer Center
Leukemia Service, Memorial Sloan Kettering Cancer Center
Haematologica Early view Mar 18, 2021 https://doi.org/10.3324/haematol.2021.278535